Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes
ICD-10 C82.26 is a billable code used to indicate a diagnosis of follicular lymphoma grade iii, unspecified, intrapelvic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade III follicular lymphoma indicates a more aggressive form of the disease, with a higher proliferation index and a greater likelihood of transformation to a more aggressive lymphoma. When classified as 'unspecified,' it indicates that the specific characteristics of the lymphoma have not been detailed in the documentation. In this case, the lymphoma is localized to the intrapelvic lymph nodes, which may include lymph nodes in the pelvic region such as the iliac or inguinal nodes. Patients may present with B-symptoms, which include fever, night sweats, and weight loss, indicating systemic involvement. The staging of follicular lymphoma is crucial for determining treatment options, which may include watchful waiting, chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms. Accurate coding is essential for appropriate treatment planning and reimbursement.
Complete pathology reports, staging information, and treatment plans must be documented.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing treatment for follicular lymphoma.
Ensure that all relevant clinical details, including grade and staging, are clearly documented to support coding.
Imaging reports must clearly indicate the location and size of lymph nodes involved.
Imaging studies performed to assess lymph node involvement in patients with suspected lymphoma.
Radiology reports should correlate findings with clinical symptoms and pathology results.
Used to monitor blood counts in patients undergoing treatment for lymphoma.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure that CBC results are correlated with lymphoma treatment.
Common treatments include chemotherapy, immunotherapy, and radiation therapy, depending on the stage and symptoms of the disease.
